FDA Approves Self-Collection for HPV Screening

The FDA has approved a new method allowing women to self-collect samples for HPV testing in private settings, such as primary-care offices, urgent-care clinics, and pharmacies. This advancement aims to increase accessibility, particularly for women of color and those in rural or underserved areas, by providing a less invasive and more convenient option for cervical cancer screening. The initiative is part of a broader effort, including partnerships with medical schools and cancer centers, to study the effectiveness of self-collection in the U.S. and potentially pave the way for at-home testing. This move could significantly contribute to the goal of eliminating cervical cancer by 2030. Read more in this article from the Washington Post.